http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a9d5f4a9c578daf7e41de7aab3f19343
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Cross |
| name | Nicholas C. P Cross Nicholas C. P. Cross Nicholas C P Cross |
| given-name | Nicholas C. P. Nicholas C P Nicholas C. P |
| organization-name | Wessex Regional Genetics Laboratory, Salisbury, UK; Faculty of Medicine, University of Southampton, Southampton, UK Faculty of Medicine, University of Southampton, Southampton, United Kingdom; and University of Southampton and Wessex Regional Genetics Laboratory, Salisbury, United Kingdom. From the Divisions of Hematology and Internal Medicine, Laboratory Genetics, and Hematopathology, Mayo Clinic, Rochester, MN; Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, United Kingdom; and Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. From the Cancer Research Campaign LaboratoriesDivision of Cancer Cell Biology, and Department of Haematology, Imperial College School of Medicine, Hammersmith Hospital; and Department of Surgery, Charing Cross Hospital, London, United Kingdom. LRF Centre for Adult Leukaemia, Royal Postgraduate Medical School Faculty of Medicine University of Southampton Southampton UK; Wessex Regional Genetics Laboratory Salisbury UK Department of Haematology Imperial College of School of Medicine Hammersmith Hospital London, England Wessex Regional Genetics Laboratory Salisbury District Hospital Salisbury UK National Genetics Reference Laboratory Wessex, Salisbury District Hospital, Salisbury, United Kingdom;; Human Genetics Division, University of Southampton School of Medicine, Southampton, United Kingdom From the LRF Centre for Adult Leukaemia, Department of Haematology, Imperial College School of Medicine, Hammersmith Campus; the Ludwig Institute for Cancer Research and Section of Virology and Cell Biology, Imperial College School of Medicine, St Mary's Campus; and the Department of Haematological Medicine, Guy's, King's and St Thomas' School of Medicine and Dentistry, King's Denmark Hill Campus, London, United Kingdom. From the Department of Haematology, Imperial College School of Medicine, Hammersmith Hospital, London, United Kingdom; Division of Cancer Services, Mater Hospital, South Brisbane, Australia; Department of Medicine and Department of Laboratories, North Shore University Hospital and New York University School of Medicine, Manhasset, New York; Nambour General Hospital, Nambour, Australia; III Medizinische Universitätsklinik, Klinikum Mannheim, Germany. Wessex Regional Genetics Laboratory, Salisbury, United Kingdom;; Faculty of Medicine, University of Southampton, Southampton, United Kingdom; National Genetics Reference Laboratory, University of Southampton, Salisbury, United Kingdom; Wessex Regional Genetics Laboratory, Salisbury and Human Genetics Division, University of Southampton, Southampton, United Kingdom Wessex Regional Genetics Laboratory, Salisbury, United Kingdom; and; Faculty of Medicine, University of Southampton, Southampton, United Kingdom From the Wessex Regional Genetics Laboratory, Salisbury, United Kingdom; the Human Genetics Division, University of Southampton, United Kingdom; Weill Medical College of Cornell University, New York, NY; the Foundation of Biomedical Research of Academy of Athens, Greece; III Medizinische Universitätsklinik, Fakultät für Klinische Medizin Mannheim der Universität Heidelberg, Heidelberg, Germany; and Royal Bournemouth Hospital, Bournemouth, United Kingdom. Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, UK Wessex Regional Genetics Laboratory, University of Southampton School of Medicine, Salisbury, United Kingdom; Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury SP2 8BJ, UK, Faculty of Medicine, University of Southampton, Southampton, UK 2Wessex Regional Genetics Laboratory, Salisbury and Human Genetics Division, University of Southampton, Southampton, United Kingdom; and Wessex Regional Genetics Laboratory Salisbury District Hospital Salisbury SP2 8BJ Wessex Regional Genetics Laboratory, Salisbury NHS Foundation Trust, Salisbury, United Kingdom;; Faculty of Medicine, University of Southampton, Southampton, United Kingdom; Human Genetics Division, University of Southampton School of Medicine, Southampton, United Kingdom; and Wessex Regional Genetics Laboratory Salisbury UK; Faculty of Medicine University of Southampton UK Faculty of Medicine University of Southampton Southampton UK Wessex Regional Genetics Laboratory, Salisbury, and Human Genetics Division, University of Southampton School of Medicine, Southampton, United Kingdom Wessex Regional Genetics Laboratory; Salisbury District Hospital; Salisbury UK; Faculty of Medicine; University of Southampton; Southampton UK Leukaemia Research Fund UK Myeloma Forum Cytogenetics Group, Wessex Regional Genetics Laboratory, Salisbury, United Kingdom Faculty of Medicine University of Southampton Southampton United Kingdom Wessex Regional Genetics Laboratory, Salisbury, and Human Genetics Division, School of Medicine, University of Southampton, Southampton, United Kingdom; Wessex Regional Genetics Laboratory Salisbury UK; School of Medicine University of Southampton Southampton UK Wessex Regional Genetics Laboratory Salisbury District Hospital Salisbury Wiltshire SP2 8BJ United Kingdom Wessex Regional Genetics Laboratory, Salisbury, United Kingdom; and UNIVERSITY OF SOUTHAMPTON From the Divisions of Hematology and Internal Medicine, Hematopathology, and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; and Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, United Kingdom. 1Wessex Regional Genetics Laboratory, Salisbury and Human Genetics Division, University of Southampton, Southampton, United Kingdom; From the Department of Haematology, Hammersmith Hospital/ICSM, London, United Kingdom. Faculty of Medicine, University of Southampton, Southampton, United Kingdom From the Department of Haematology, Hammersmith Hospital, Imperial College School of Medicine, London, England. Wessex Regional Genetics Laboratory, Salisbury, United Kingdom;; Human Genetics Division, University of Southampton School of Medicine, Southampton, United Kingdom; and Faculty of Medicine, University of Southampton, Southampton, United Kingdom;; Wessex Regional Genetics Laboratory, Salisbury, United Kingdom; National Genetics Reference Laboratory Salisbury NHS Foundation Trust Salisbury UK; Faculty of Medicine University of Southampton Southampton UK Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, United Kingdom; Correspondence: Junia V. Melo, Dept of Haematology–ICSM, Hammersmith Hospital, Ducane Road, London W12 0NN, United Kingdom; e-mail: Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom;; Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, United Kingdom; From the Department of Haematology, Imperial College at Hammersmith Hospital, London, United Kingdom; and the National Genetics Reference Laboratory, University of Southampton, Salisbury, United Kingdom. Faculty of Medicine, University of Southampton, and Wessex Regional Genetics Laboratory, Salisbury, United Kingdom Wessex Regional Genetics Laboratory, Salisbury and Human Genetics Division, University of Southampton, Salisbury District Hospital, Salisbury SP2 8BJ, U.K. Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, United Kingdom; and; Faculty of Medicine, University of Southampton, Southampton, United Kingdom Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, United Kingdom;; Human Genetics Division, University of Southampton School of Medicine, Southampton, United Kingdom; |
Incoming Links
Total number of triples: 189.